Mario Diego-Perez

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Cannabinoid WIN55,212-2 restores bronchial epithelium by regulating oxidative stress and STAT6 phosphorylation.

Cannabinoid WIN55,212-2 restores bronchial epithelium by regulating oxidative stress and STAT6 phosphorylation.

Journal: The Journal of allergy and clinical immunology
Published: January 02, 2025

Nutritional and environmental exposures in athletes: Implications on the epithelial barrier function.

Nutritional and environmental exposures in athletes: Implications on the epithelial barrier function.

Journal: Allergy
Published: July 30, 2024

A mucosal vaccine prevents eosinophilic allergic airway inflammation by modulating immune responses to allergens in a murine model of airway disease.

A mucosal vaccine prevents eosinophilic allergic airway inflammation by modulating immune responses to allergens in a murine model of airway disease.

Journal: Nature communications
Published: June 14, 2024

Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation.

Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation.

Journal: Frontiers in immunology
Published: January 18, 2023

Cannabinoid WIN55212-2 impairs peanut-allergic sensitization and promotes the generation of allergen-specific regulatory T cells.

Cannabinoid WIN55212-2 impairs peanut-allergic sensitization and promotes the generation of allergen-specific regulatory T cells.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: October 25, 2021

Differentiation of bronchial epithelial spheroids in the presence of IL-13 recapitulates characteristic features of asthmatic airway epithelia.

Differentiation of bronchial epithelial spheroids in the presence of IL-13 recapitulates characteristic features of asthmatic airway epithelia.

Journal: Allergy
Published: October 22, 2021

The cannabinoid WIN55212-2 suppresses effector T-cell responses and promotes regulatory T cells in human tonsils.

The cannabinoid WIN55212-2 suppresses effector T-cell responses and promotes regulatory T cells in human tonsils.

Journal: Allergy
Published: September 14, 2021

Allergoid-mannan conjugates imprint tolerogenic features in human macrophages.

Allergoid-mannan conjugates imprint tolerogenic features in human macrophages.

Journal: Allergy
Published: June 15, 2021

Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming.

Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming.

Journal: Mucosal immunology
Published: May 05, 2021

Allergoid-mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring.

Allergoid-mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring.

Journal: The Journal of allergy and clinical immunology
Published: February 12, 2021

The cannabinoid WIN55212-2 restores rhinovirus-induced epithelial barrier disruption.

The cannabinoid WIN55212-2 restores rhinovirus-induced epithelial barrier disruption.

Journal: Allergy
Published: September 19, 2020

The Role of Cannabinoids in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2020.

The Role of Cannabinoids in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2020.

Journal: International archives of allergy and immunology
Published: May 27, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026